Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2040.2520 (+0.99 %)

PREV CLOSE ( ) 2020.25

OPEN PRICE ( ) 2059.70

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 15842

TODAY'S LOW / HIGH ( )2021.55 2059.70

52 WK LOW / HIGH ( )1909.9 2726.75

NSE2038.8014.8 (+0.73 %)

PREV CLOSE( ) 2024.00

OPEN PRICE ( ) 2038.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 2038.80 (3)

VOLUME 542413

TODAY'S LOW / HIGH( ) 2020.30 2052.60

52 WK LOW / HIGH ( )1909.7 2716.5

Quarters

Select year

( in Million)

Particulars

Dec 2025

Sep 2025

Jun 2025

Mar 2025

Audited / UnAudited

UnAudited

Net Sales

35672

36971.6

35703.5

30793.7

Total Expenditure

26477.7

27758.3

27235.8

23961.8

PBIDT (Excl OI)

9194.3

9213.3

8467.7

6831.9

Other Income

727.5

918.7

798.8

2513.3

Operating Profit

9921.8

10132

9266.5

9345.2

Interest

1572

1696.8

1706.5

1905.4

Exceptional Items

-1065.9

PBDT

7283.9

8435.2

7560

7439.8

Depreciation

2226

2218.2

2186.8

2308.7

Profit Before Tax

5057.9

6217

5373.2

5131.1

Tax

951.2

1038.4

958.7

864.4

Provisions and contingencies

Profit After Tax

4106.7

5178.6

4414.5

4266.7

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

4106.7

5178.6

4414.5

4223.3

Minority Interest

-51.3

-86.7

-63

-38.8

Shares of Associates

32.1

23.2

31.7

23.2

Other related items

Misc. Expenses Written off

Consolidated Net Profit

4087.5

5115.1

4383.2

4207.7

Equity Capital

412.8

412.73

412.6

Face Value (IN RS)

Reserves

Calculated EPS

9.90

12.39

10.62

10.19

Calculated EPS (Annualised)

39.60

49.56

42.48

40.79

No of Public Share Holdings

112844460

112797878

112768136

112617915

% of Public Share Holdings

27.34

27.33

27.32

27.3

PBIDTM% (Excl OI)

25.77

24.91

23.71

22.18

PBIDTM%

27.81

27.40

25.95

30.34

PBDTM%

20.41

22.81

21.17

24.16

PBTM%

14.17

16.81

15.04

16.66

PATM%

11.51

14.00

12.36

13.85

Notes

Risk Disclosures on Derivatives

Quarterly Results

MANKIND PHARMA LTD.